CN Stock MarketDetailed Quotes

Pharmaron Beijing (300759)

Watchlist
  • 25.89
  • -0.79-2.96%
Trading May 22 10:17 CST
47.57BMarket Cap28.08P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pharmaron Beijing (300759) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
88.40%2.38B
-39.79%1.02B
-39.81%1.2B
-45.78%1.3B
-72.75%1.26B
-71.45%1.69B
-2.80%2B
-4.45%2.4B
125.41%4.63B
295.26%5.92B
Transactional financial assets
-57.75%597.95M
-35.97%714.07M
80.13%1.08B
138.12%859.82M
146.21%1.42B
87.65%1.12B
-35.42%596.88M
-43.33%361.09M
17.04%574.79M
-20.26%594.33M
Notes receivable and accounts receivable
16.78%2.67B
12.77%2.72B
9.10%2.48B
17.13%2.55B
9.63%2.29B
7.65%2.41B
2.27%2.27B
1.92%2.18B
1.00%2.09B
19.14%2.24B
-Notes receivable
70.14%10.85M
221.67%14.81M
1,050.40%11.98M
--7.94M
--6.38M
3,505.86%4.6M
--1.04M
----
----
--127.66K
-Accounts receivable
16.63%2.66B
12.37%2.71B
8.62%2.47B
16.77%2.54B
9.33%2.28B
7.45%2.41B
2.22%2.27B
1.92%2.18B
1.00%2.09B
19.14%2.24B
Other receivables (including interest and dividends)
-11.52%96.91M
-45.82%85.96M
-26.90%120.53M
-25.96%107.52M
-22.45%109.53M
40.25%158.67M
72.79%164.88M
30.32%145.23M
18.76%141.24M
19.43%113.13M
-Other receivable
----
----
----
-25.96%107.52M
----
40.25%158.67M
----
30.32%145.23M
----
19.43%113.13M
Contractual assets
-1.16%496.83M
1.75%465.83M
3.04%469.74M
1.02%431.65M
18.41%502.64M
16.12%457.81M
16.28%455.88M
8.37%427.29M
7.60%424.48M
18.54%394.27M
Advance payment
210.35%101.93M
39.69%18.92M
44.44%36.94M
-16.12%21.84M
26.08%32.84M
-23.96%13.54M
-13.19%25.57M
-8.68%26.04M
-12.84%26.05M
-22.70%17.81M
Inventories
45.18%1.69B
31.85%1.47B
16.76%1.4B
9.86%1.31B
8.88%1.17B
10.22%1.12B
20.17%1.2B
14.30%1.19B
-0.10%1.07B
-2.73%1.01B
Non-current assets due within one year
----
----
----
----
----
----
----
----
3,899.46%145.66M
5,353.66%144.33M
Other current assets
69.60%1.01B
97.47%1.26B
166.73%1.03B
194.72%1.01B
72.99%596.08M
56.00%637.62M
7.56%385.62M
-19.08%343.27M
5.60%344.56M
-55.42%408.74M
Total current assets
22.56%9.05B
2.23%7.78B
10.07%7.81B
7.38%7.59B
-21.84%7.38B
-30.04%7.61B
-1.70%7.1B
-4.84%7.07B
44.06%9.45B
66.38%10.87B
Non Current assets
Other non-current financial assets
65.31%572.14M
121.50%518.45M
115.66%508.65M
99.73%466.89M
22.00%346.11M
-17.01%234.06M
-18.60%235.86M
-8.32%233.76M
7.83%283.7M
17.98%282.03M
Long-term equity investment
-11.19%646M
-1.41%639.86M
-18.01%702.03M
-2.94%712.68M
-1.31%727.36M
-10.23%648.98M
27.87%856.22M
12.82%734.24M
15.49%737.05M
14.76%722.95M
Fixed assets
----
----
----
8.17%8B
----
20.20%7.81B
----
22.76%7.4B
----
14.69%6.5B
Constru in process
----
----
----
30.41%2.61B
----
-14.39%2.25B
----
-17.04%2B
----
57.56%2.63B
Productive biological assets
1.74%177.9M
-1.39%172.57M
-1.93%153.05M
0.56%157.43M
11.44%174.86M
11.02%175M
-18.55%156.07M
-16.89%156.56M
-12.65%156.91M
-11.45%157.63M
Intangible assets
39.51%1.17B
51.28%1.2B
7.21%858.65M
11.05%872.83M
6.36%837.51M
0.25%791M
1.89%800.92M
-2.37%786.01M
-4.99%787.46M
-1.68%789.06M
Goodwill
19.94%3.54B
29.89%3.59B
4.89%2.98B
7.06%2.98B
6.10%2.95B
-0.73%2.76B
2.81%2.84B
-0.94%2.79B
3.36%2.78B
3.46%2.78B
Long deferred expense
-10.14%590.9M
-8.92%617.99M
-8.26%620.04M
-8.62%644.39M
30.50%657.6M
30.36%678.5M
47.53%675.86M
47.08%705.14M
4.80%503.91M
4.85%520.47M
Deferred tax assets
27.55%289.63M
36.44%262.91M
20.56%250.18M
20.40%229.17M
17.41%227.07M
25.76%192.68M
34.69%207.51M
37.86%190.34M
178.77%193.4M
160.62%153.22M
Usufruct assets
-0.78%533.49M
-10.95%498.87M
-9.03%532.56M
-10.27%554.66M
-16.64%537.66M
-27.77%560.22M
-28.55%585.42M
-28.64%618.12M
-29.29%644.99M
-18.38%775.63M
Other non current assets
113.55%514.52M
143.00%524.13M
55.93%493.69M
17.28%369.25M
-29.61%240.94M
-25.93%215.69M
20.67%316.61M
-2.84%314.85M
-22.67%342.29M
-33.65%291.22M
Total non current assets
15.12%19.51B
18.36%19.32B
9.20%17.99B
10.54%17.6B
7.30%16.95B
4.59%16.32B
7.97%16.47B
6.46%15.93B
9.02%15.8B
11.79%15.6B
Total assets
17.38%28.56B
13.23%27.09B
9.47%25.8B
9.57%25.2B
-3.61%24.33B
-9.63%23.93B
4.87%23.57B
2.71%23B
19.94%25.24B
29.20%26.48B
Liabilities
Current liabilities
Short term loan
49.75%1.2B
65.42%1.27B
92.21%1.24B
80.23%1B
49.53%799.19M
32.56%764.97M
20.53%644.67M
20.49%556.13M
-19.52%534.47M
-12.93%577.07M
Transactional financial liabilities
----
----
----
----
----
----
-80.47%26.54M
-70.84%50.03M
29.07%32.97M
----
Notes payable and accounts payable
29.73%628.25M
27.14%606.59M
16.28%564.64M
4.93%527.83M
25.75%484.26M
15.74%477.09M
21.11%485.59M
20.78%503.04M
-10.17%385.09M
1.45%412.22M
-Accounts payable
29.73%628.25M
27.14%606.59M
16.28%564.64M
4.93%527.83M
25.75%484.26M
15.74%477.09M
21.11%485.59M
20.78%503.04M
-10.17%385.09M
1.45%412.22M
Contract liabilities
16.83%1B
15.06%960.61M
24.40%1.12B
34.34%1.07B
2.66%859.18M
12.69%834.86M
5.31%899.24M
-8.78%796.97M
5.66%836.88M
-10.97%740.87M
Salaries payable
19.31%948.03M
22.96%874.33M
32.57%808.32M
15.98%680.65M
9.17%794.59M
6.35%711.1M
-6.91%609.74M
-0.36%586.88M
3.37%727.83M
7.23%668.66M
Taxs payable
17.21%242.36M
-5.42%207.18M
-12.03%218.62M
-36.56%140.9M
-12.41%206.78M
-7.94%219.05M
-0.17%248.53M
2.41%222.09M
21.62%236.07M
26.38%237.95M
Other payable (including interest and dividends)
5.44%656.65M
13.09%802.46M
-3.25%740.28M
47.37%1.06B
-3.83%622.76M
12.54%709.61M
32.78%765.14M
-29.70%720.54M
-22.85%647.54M
-30.57%630.54M
-Dividend payable
----
--10M
----
493.12%349.05M
----
----
----
-83.61%58.85M
----
----
-Other payable
----
----
----
7.72%712.79M
----
12.54%709.61M
----
-0.63%661.68M
----
-30.42%630.54M
Non current liabilities due within one year
758.69%3.66B
739.14%3.62B
4.38%471.8M
4.19%468.21M
29.31%426.7M
28.66%431.85M
62.66%451.99M
69.43%449.39M
25.82%329.99M
40.45%335.66M
Other current liabilities
-9.99%24.9M
-16.54%23.64M
9.16%26.85M
-2.52%24.97M
9.49%27.66M
15.20%28.32M
-15.93%24.6M
9.42%25.62M
2.89%25.26M
10.74%24.59M
Total current liabilities
98.17%8.37B
98.01%8.36B
24.97%5.19B
27.29%4.98B
12.45%4.22B
15.58%4.22B
11.93%4.16B
-3.26%3.91B
-4.54%3.76B
-6.59%3.65B
Current liabilities
Long term loan
-57.69%1.84B
-59.52%1.77B
-0.78%4.3B
-2.72%4.21B
-0.79%4.36B
1.61%4.38B
396.25%4.33B
419.98%4.33B
474.88%4.39B
503.94%4.31B
Bonds payable
----
----
----
----
----
----
----
-99.74%10.26M
-32.42%2.53B
4.03%3.89B
Deferred tax liabilities
28.39%401.75M
36.07%397.15M
19.38%314.56M
34.41%324.61M
17.35%312.9M
0.63%291.87M
2.54%263.49M
-9.32%241.51M
-0.33%266.64M
11.12%290.04M
Long term deferred income
4.29%434.93M
8.02%442.86M
13.51%433.09M
7.85%415.08M
7.90%417.04M
4.66%409.98M
34.01%381.53M
34.46%384.87M
76.26%386.49M
157.07%391.71M
Lease liabilities
5.52%396.3M
-5.45%379.42M
-7.62%381.28M
-10.95%401.19M
-19.43%375.59M
-31.42%401.31M
-33.11%412.71M
-32.97%450.54M
-35.33%466.16M
-23.05%585.2M
Other non current liabilities
----
----
----
----
----
----
----
----
-27.25%89.37M
4.90%117.58M
Total non current liabilities
-43.68%3.08B
-45.42%2.99B
0.69%5.43B
-1.18%5.35B
-32.81%5.46B
-42.82%5.48B
-10.74%5.39B
-10.37%5.41B
39.27%8.13B
66.96%9.58B
Total liabilities
18.17%11.45B
17.01%11.36B
11.26%10.62B
10.76%10.33B
-18.51%9.69B
-26.70%9.7B
-2.11%9.54B
-7.52%9.32B
21.63%11.89B
37.15%13.24B
Shareholders equity
Paid-in capital
3.32%1.84B
0.04%1.78B
-0.51%1.78B
-0.51%1.78B
-0.51%1.78B
-0.51%1.78B
0.04%1.79B
0.04%1.79B
50.05%1.79B
50.05%1.79B
Other equity instruments
----
----
----
----
----
----
----
----
-40.55%118.04M
0.00%198.55M
Capital reserve funds
20.95%6.08B
-1.16%4.95B
-5.00%4.93B
-4.86%4.92B
-4.39%5.03B
-4.09%5.01B
2.67%5.19B
3.93%5.17B
-1.19%5.26B
-0.62%5.22B
Surplus reserve funds
9.24%889.42M
9.24%889.42M
32.82%814.22M
32.82%814.22M
32.82%814.22M
32.82%814.22M
45.47%613.04M
45.47%613.04M
45.47%613.04M
45.47%613.04M
Retained profit
18.76%8.01B
19.18%7.68B
15.28%7.23B
13.88%6.79B
24.16%6.75B
23.79%6.44B
27.12%6.27B
30.19%5.96B
20.76%5.44B
25.34%5.2B
Less:Treasury stock
-27.92%304.89M
-26.76%304.89M
-42.25%304.89M
-36.34%304.89M
-8.73%422.98M
-10.18%416.27M
13.91%527.94M
3.35%478.97M
-28.72%463.45M
-30.62%463.45M
Other composite income
-156.92%-56.1M
1,025.51%71.8M
215.67%163.24M
733.68%268.3M
265.06%98.55M
-60.61%-7.76M
285.80%51.71M
-215.29%-42.34M
-2,352.69%-59.7M
-273.55%-4.83M
Shareholders equity without minority interests
17.21%16.46B
10.61%15.06B
9.16%14.61B
9.63%14.27B
10.68%14.04B
8.46%13.62B
12.45%13.39B
12.81%13.01B
15.55%12.69B
19.04%12.56B
Minority interests
8.64%656.16M
11.74%674.38M
-10.91%569.14M
-8.45%603.1M
-9.85%603.95M
-11.41%603.54M
-22.25%638.87M
-14.62%658.78M
126.95%669.92M
133.90%681.25M
Total shareholder equity
16.85%17.11B
10.66%15.74B
8.24%15.18B
8.76%14.87B
9.65%14.65B
7.44%14.22B
10.21%14.03B
11.09%13.67B
18.47%13.36B
22.12%13.24B
Total liabilityies and equity
17.38%28.56B
13.23%27.09B
9.47%25.8B
9.57%25.2B
-3.61%24.33B
-9.63%23.93B
4.87%23.57B
2.71%23B
19.94%25.24B
29.20%26.48B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
--
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
--
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds 88.40%2.38B-39.79%1.02B-39.81%1.2B-45.78%1.3B-72.75%1.26B-71.45%1.69B-2.80%2B-4.45%2.4B125.41%4.63B295.26%5.92B
Transactional financial assets -57.75%597.95M-35.97%714.07M80.13%1.08B138.12%859.82M146.21%1.42B87.65%1.12B-35.42%596.88M-43.33%361.09M17.04%574.79M-20.26%594.33M
Notes receivable and accounts receivable 16.78%2.67B12.77%2.72B9.10%2.48B17.13%2.55B9.63%2.29B7.65%2.41B2.27%2.27B1.92%2.18B1.00%2.09B19.14%2.24B
-Notes receivable 70.14%10.85M221.67%14.81M1,050.40%11.98M--7.94M--6.38M3,505.86%4.6M--1.04M----------127.66K
-Accounts receivable 16.63%2.66B12.37%2.71B8.62%2.47B16.77%2.54B9.33%2.28B7.45%2.41B2.22%2.27B1.92%2.18B1.00%2.09B19.14%2.24B
Other receivables (including interest and dividends) -11.52%96.91M-45.82%85.96M-26.90%120.53M-25.96%107.52M-22.45%109.53M40.25%158.67M72.79%164.88M30.32%145.23M18.76%141.24M19.43%113.13M
-Other receivable -------------25.96%107.52M----40.25%158.67M----30.32%145.23M----19.43%113.13M
Contractual assets -1.16%496.83M1.75%465.83M3.04%469.74M1.02%431.65M18.41%502.64M16.12%457.81M16.28%455.88M8.37%427.29M7.60%424.48M18.54%394.27M
Advance payment 210.35%101.93M39.69%18.92M44.44%36.94M-16.12%21.84M26.08%32.84M-23.96%13.54M-13.19%25.57M-8.68%26.04M-12.84%26.05M-22.70%17.81M
Inventories 45.18%1.69B31.85%1.47B16.76%1.4B9.86%1.31B8.88%1.17B10.22%1.12B20.17%1.2B14.30%1.19B-0.10%1.07B-2.73%1.01B
Non-current assets due within one year --------------------------------3,899.46%145.66M5,353.66%144.33M
Other current assets 69.60%1.01B97.47%1.26B166.73%1.03B194.72%1.01B72.99%596.08M56.00%637.62M7.56%385.62M-19.08%343.27M5.60%344.56M-55.42%408.74M
Total current assets 22.56%9.05B2.23%7.78B10.07%7.81B7.38%7.59B-21.84%7.38B-30.04%7.61B-1.70%7.1B-4.84%7.07B44.06%9.45B66.38%10.87B
Non Current assets
Other non-current financial assets 65.31%572.14M121.50%518.45M115.66%508.65M99.73%466.89M22.00%346.11M-17.01%234.06M-18.60%235.86M-8.32%233.76M7.83%283.7M17.98%282.03M
Long-term equity investment -11.19%646M-1.41%639.86M-18.01%702.03M-2.94%712.68M-1.31%727.36M-10.23%648.98M27.87%856.22M12.82%734.24M15.49%737.05M14.76%722.95M
Fixed assets ------------8.17%8B----20.20%7.81B----22.76%7.4B----14.69%6.5B
Constru in process ------------30.41%2.61B-----14.39%2.25B-----17.04%2B----57.56%2.63B
Productive biological assets 1.74%177.9M-1.39%172.57M-1.93%153.05M0.56%157.43M11.44%174.86M11.02%175M-18.55%156.07M-16.89%156.56M-12.65%156.91M-11.45%157.63M
Intangible assets 39.51%1.17B51.28%1.2B7.21%858.65M11.05%872.83M6.36%837.51M0.25%791M1.89%800.92M-2.37%786.01M-4.99%787.46M-1.68%789.06M
Goodwill 19.94%3.54B29.89%3.59B4.89%2.98B7.06%2.98B6.10%2.95B-0.73%2.76B2.81%2.84B-0.94%2.79B3.36%2.78B3.46%2.78B
Long deferred expense -10.14%590.9M-8.92%617.99M-8.26%620.04M-8.62%644.39M30.50%657.6M30.36%678.5M47.53%675.86M47.08%705.14M4.80%503.91M4.85%520.47M
Deferred tax assets 27.55%289.63M36.44%262.91M20.56%250.18M20.40%229.17M17.41%227.07M25.76%192.68M34.69%207.51M37.86%190.34M178.77%193.4M160.62%153.22M
Usufruct assets -0.78%533.49M-10.95%498.87M-9.03%532.56M-10.27%554.66M-16.64%537.66M-27.77%560.22M-28.55%585.42M-28.64%618.12M-29.29%644.99M-18.38%775.63M
Other non current assets 113.55%514.52M143.00%524.13M55.93%493.69M17.28%369.25M-29.61%240.94M-25.93%215.69M20.67%316.61M-2.84%314.85M-22.67%342.29M-33.65%291.22M
Total non current assets 15.12%19.51B18.36%19.32B9.20%17.99B10.54%17.6B7.30%16.95B4.59%16.32B7.97%16.47B6.46%15.93B9.02%15.8B11.79%15.6B
Total assets 17.38%28.56B13.23%27.09B9.47%25.8B9.57%25.2B-3.61%24.33B-9.63%23.93B4.87%23.57B2.71%23B19.94%25.24B29.20%26.48B
Liabilities
Current liabilities
Short term loan 49.75%1.2B65.42%1.27B92.21%1.24B80.23%1B49.53%799.19M32.56%764.97M20.53%644.67M20.49%556.13M-19.52%534.47M-12.93%577.07M
Transactional financial liabilities -------------------------80.47%26.54M-70.84%50.03M29.07%32.97M----
Notes payable and accounts payable 29.73%628.25M27.14%606.59M16.28%564.64M4.93%527.83M25.75%484.26M15.74%477.09M21.11%485.59M20.78%503.04M-10.17%385.09M1.45%412.22M
-Accounts payable 29.73%628.25M27.14%606.59M16.28%564.64M4.93%527.83M25.75%484.26M15.74%477.09M21.11%485.59M20.78%503.04M-10.17%385.09M1.45%412.22M
Contract liabilities 16.83%1B15.06%960.61M24.40%1.12B34.34%1.07B2.66%859.18M12.69%834.86M5.31%899.24M-8.78%796.97M5.66%836.88M-10.97%740.87M
Salaries payable 19.31%948.03M22.96%874.33M32.57%808.32M15.98%680.65M9.17%794.59M6.35%711.1M-6.91%609.74M-0.36%586.88M3.37%727.83M7.23%668.66M
Taxs payable 17.21%242.36M-5.42%207.18M-12.03%218.62M-36.56%140.9M-12.41%206.78M-7.94%219.05M-0.17%248.53M2.41%222.09M21.62%236.07M26.38%237.95M
Other payable (including interest and dividends) 5.44%656.65M13.09%802.46M-3.25%740.28M47.37%1.06B-3.83%622.76M12.54%709.61M32.78%765.14M-29.70%720.54M-22.85%647.54M-30.57%630.54M
-Dividend payable ------10M----493.12%349.05M-------------83.61%58.85M--------
-Other payable ------------7.72%712.79M----12.54%709.61M-----0.63%661.68M-----30.42%630.54M
Non current liabilities due within one year 758.69%3.66B739.14%3.62B4.38%471.8M4.19%468.21M29.31%426.7M28.66%431.85M62.66%451.99M69.43%449.39M25.82%329.99M40.45%335.66M
Other current liabilities -9.99%24.9M-16.54%23.64M9.16%26.85M-2.52%24.97M9.49%27.66M15.20%28.32M-15.93%24.6M9.42%25.62M2.89%25.26M10.74%24.59M
Total current liabilities 98.17%8.37B98.01%8.36B24.97%5.19B27.29%4.98B12.45%4.22B15.58%4.22B11.93%4.16B-3.26%3.91B-4.54%3.76B-6.59%3.65B
Current liabilities
Long term loan -57.69%1.84B-59.52%1.77B-0.78%4.3B-2.72%4.21B-0.79%4.36B1.61%4.38B396.25%4.33B419.98%4.33B474.88%4.39B503.94%4.31B
Bonds payable -----------------------------99.74%10.26M-32.42%2.53B4.03%3.89B
Deferred tax liabilities 28.39%401.75M36.07%397.15M19.38%314.56M34.41%324.61M17.35%312.9M0.63%291.87M2.54%263.49M-9.32%241.51M-0.33%266.64M11.12%290.04M
Long term deferred income 4.29%434.93M8.02%442.86M13.51%433.09M7.85%415.08M7.90%417.04M4.66%409.98M34.01%381.53M34.46%384.87M76.26%386.49M157.07%391.71M
Lease liabilities 5.52%396.3M-5.45%379.42M-7.62%381.28M-10.95%401.19M-19.43%375.59M-31.42%401.31M-33.11%412.71M-32.97%450.54M-35.33%466.16M-23.05%585.2M
Other non current liabilities ---------------------------------27.25%89.37M4.90%117.58M
Total non current liabilities -43.68%3.08B-45.42%2.99B0.69%5.43B-1.18%5.35B-32.81%5.46B-42.82%5.48B-10.74%5.39B-10.37%5.41B39.27%8.13B66.96%9.58B
Total liabilities 18.17%11.45B17.01%11.36B11.26%10.62B10.76%10.33B-18.51%9.69B-26.70%9.7B-2.11%9.54B-7.52%9.32B21.63%11.89B37.15%13.24B
Shareholders equity
Paid-in capital 3.32%1.84B0.04%1.78B-0.51%1.78B-0.51%1.78B-0.51%1.78B-0.51%1.78B0.04%1.79B0.04%1.79B50.05%1.79B50.05%1.79B
Other equity instruments ---------------------------------40.55%118.04M0.00%198.55M
Capital reserve funds 20.95%6.08B-1.16%4.95B-5.00%4.93B-4.86%4.92B-4.39%5.03B-4.09%5.01B2.67%5.19B3.93%5.17B-1.19%5.26B-0.62%5.22B
Surplus reserve funds 9.24%889.42M9.24%889.42M32.82%814.22M32.82%814.22M32.82%814.22M32.82%814.22M45.47%613.04M45.47%613.04M45.47%613.04M45.47%613.04M
Retained profit 18.76%8.01B19.18%7.68B15.28%7.23B13.88%6.79B24.16%6.75B23.79%6.44B27.12%6.27B30.19%5.96B20.76%5.44B25.34%5.2B
Less:Treasury stock -27.92%304.89M-26.76%304.89M-42.25%304.89M-36.34%304.89M-8.73%422.98M-10.18%416.27M13.91%527.94M3.35%478.97M-28.72%463.45M-30.62%463.45M
Other composite income -156.92%-56.1M1,025.51%71.8M215.67%163.24M733.68%268.3M265.06%98.55M-60.61%-7.76M285.80%51.71M-215.29%-42.34M-2,352.69%-59.7M-273.55%-4.83M
Shareholders equity without minority interests 17.21%16.46B10.61%15.06B9.16%14.61B9.63%14.27B10.68%14.04B8.46%13.62B12.45%13.39B12.81%13.01B15.55%12.69B19.04%12.56B
Minority interests 8.64%656.16M11.74%674.38M-10.91%569.14M-8.45%603.1M-9.85%603.95M-11.41%603.54M-22.25%638.87M-14.62%658.78M126.95%669.92M133.90%681.25M
Total shareholder equity 16.85%17.11B10.66%15.74B8.24%15.18B8.76%14.87B9.65%14.65B7.44%14.22B10.21%14.03B11.09%13.67B18.47%13.36B22.12%13.24B
Total liabilityies and equity 17.38%28.56B13.23%27.09B9.47%25.8B9.57%25.2B-3.61%24.33B-9.63%23.93B4.87%23.57B2.71%23B19.94%25.24B29.20%26.48B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Ernst & Young Huaming Accounting Firm (Special General Partnership)------Ernst & Young Huaming Accounting Firm (Special General Partnership)------Ernst & Young Huaming Accounting Firm (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 -1.88%
Sample Name
Sample Code
 -2.16%
Sample Name
Sample Code
 -3.28%
4
SHANGHAI PECHEM
00338
-4.96%
5
KUNLUN ENERGY
00135
-5.56%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +45.24%
Sample Name
Sample Code
 +33.55%
Sample Name
Sample Code
 +23.43%
4
Business-intelligence Of Oriental Nations Corporation
300166
+20.46%
5
MeiG Smart Technology
002881
+18.59%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 21, Eastern Time, according to Iran's Labor News Agency (ILNA), citing Al Arabiya television, the United States and Iran have reached Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -